From science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure.

DINCH HBM4EU Human biomonitoring (HBM) Phthalates Science-policy uptake indicator

Journal

International journal of hygiene and environmental health
ISSN: 1618-131X
Titre abrégé: Int J Hyg Environ Health
Pays: Germany
ID NLM: 100898843

Informations de publication

Date de publication:
01 2023
Historique:
received: 08 07 2022
revised: 19 10 2022
accepted: 07 11 2022
pubmed: 27 11 2022
medline: 7 12 2022
entrez: 26 11 2022
Statut: ppublish

Résumé

Within the European Human Biomonitoring (HBM) Initiative HBM4EU we derived HBM indicators that were designed to help answering key policy questions and support chemical policies. The result indicators convey information on chemicals exposure of different age groups, sexes, geographical regions and time points by comparing median exposure values. If differences are observed for one group or the other, policy measures or risk management options can be implemented. Impact indicators support health risk assessment by comparing exposure values with health-based guidance values, such as human biomonitoring guidance values (HBM-GVs). In general, the indicators should be designed to translate complex scientific information into short and clear messages and make it accessible to policy makers but also to a broader audience such as stakeholders (e.g. NGO's), other scientists and the general public. Based on harmonized data from the HBM4EU Aligned Studies (2014-2021), the usefulness of our indicators was demonstrated for the age group children (6-11 years), using two case examples: one phthalate (Diisobutyl phthalate: DiBP) and one non-phthalate substitute (Di-isononyl cyclohexane-1,2- dicarboxylate: DINCH). For the comparison of age groups, these were compared to data for teenagers (12-18 years), and time periods were compared using data from the DEMOCOPHES project (2011-2012). Our result indicators proved to be suitable for demonstrating the effectiveness of policy measures for DiBP and the need of continuous monitoring for DINCH. They showed similar exposure for boys and girls, indicating that there is no need for gender focused interventions and/or no indication of sex-specific exposure patterns. They created a basis for a targeted approach by highlighting relevant geographical differences in internal exposure. An adequate data basis is essential for revealing differences for all indicators. This was particularly evident in our studies on the indicators on age differences. The impact indicator revealed that health risks based on exposure to DiBP cannot be excluded. This is an indication or flag for risk managers and policy makers that exposure to DiBP still is a relevant health issue. HBM indicators derived within HBM4EU are a valuable and important complement to existing indicator lists in the context of environment and health. Their applicability, current shortcomings and solution strategies are outlined.

Identifiants

pubmed: 36434900
pii: S1438-4639(22)00156-0
doi: 10.1016/j.ijheh.2022.114073
pmc: PMC9758616
pii:
doi:

Substances chimiques

phthalic acid 6O7F7IX66E
Phthalic Acids 0
Carboxylic Acids 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114073

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier GmbH.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Références

Int J Hyg Environ Health. 2022 Sep;246:114052
pubmed: 36323174
Int J Hyg Environ Health. 2020 Jan;223(1):93-105
pubmed: 31669154
Int J Environ Res Public Health. 2022 May 18;19(10):
pubmed: 35627658
EFSA J. 2019 Dec 11;17(12):e05838
pubmed: 32626195
Int J Hyg Environ Health. 2021 May;234:113740
pubmed: 33774419
Environ Int. 2019 Nov;132:105103
pubmed: 31470218
Environ Health Perspect. 2015 Mar;123(3):255-63
pubmed: 25493439
Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):179-188
pubmed: 27923611
Int J Hyg Environ Health. 2020 Apr;225:113444
pubmed: 32058939
Int J Hyg Environ Health. 2019 Sep;222(8):1084-1092
pubmed: 31378638
Arch Toxicol. 2005 Jul;79(7):367-76
pubmed: 15700144
Int J Environ Res Public Health. 2018 Sep 21;15(10):
pubmed: 30248963
Environ Pollut. 2021 May 1;276:116724
pubmed: 33631684
EFSA J. 2020 Sep 17;18(9):e06223
pubmed: 32994824
Chemosphere. 2022 Jan;286(Pt 3):131858
pubmed: 34399256
Int J Hyg Environ Health. 2021 Jul;236:113780
pubmed: 34126298
Int J Hyg Environ Health. 2021 May;234:113722
pubmed: 33711757
Int J Hyg Environ Health. 2021 Jul;236:113778
pubmed: 34089975
Environ Int. 2020 Apr;137:105467
pubmed: 32036120
Int J Hyg Environ Health. 2014 Jul;217(6):653-61
pubmed: 24405937
Int J Environ Res Public Health. 2022 Jun 01;19(11):
pubmed: 35682369
Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):94-97
pubmed: 28284775
Int J Hyg Environ Health. 2007 Jan;210(1):9-19
pubmed: 17182279
Int J Hyg Environ Health. 2020 Sep;230:113622
pubmed: 33045523
Int J Hyg Environ Health. 2020 Mar;224:113428
pubmed: 31978726
Environ Health Perspect. 2004 Mar;112(3):331-8
pubmed: 14998749
Environ Int. 2018 Nov;120:544-562
pubmed: 30170309
Int J Hyg Environ Health. 2021 Aug;237:113809
pubmed: 34455198
Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):282-298
pubmed: 28159478
Environ Res. 2022 Jun;209:112885
pubmed: 35131323
Int J Hyg Environ Health. 2020 Aug;229:113397
pubmed: 31585790
Risk Anal. 2006 Jun;26(3):803-24
pubmed: 16834635
Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):130-141
pubmed: 27863804
Mol Cell Endocrinol. 2020 Jan 1;499:110581
pubmed: 31525431
Environ Sci Technol. 2013 Jan 15;47(2):958-67
pubmed: 23234290
Toxics. 2022 Jan 26;10(2):
pubmed: 35202244
Endocr Dev. 2009;14:167-73
pubmed: 19293583

Auteurs

Antje Gerofke (A)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany. Electronic address: antje.gerofke@uba.de.

Madlen David (M)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Phillipp Schmidt (P)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Joana Lobo Vicente (JL)

European Environment Agency, Kongens Nytorv 6, 1050, Copenhagen, Denmark.

Jurgen Buekers (J)

VITO - Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium.

Liese Gilles (L)

VITO - Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium.

Ann Colles (A)

VITO - Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium.

Jos Bessems (J)

VITO - Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium.

Michiel Bastiaensen (M)

Toxicological Center, University of Antwerp, 2610 Wilrijk, Belgium.

Adrian Covaci (A)

Toxicological Center, University of Antwerp, 2610 Wilrijk, Belgium.

Elly Den Hond (E)

Provincial Institute of Hygiene, Antwerp, Belgium.

Gudrun Koppen (G)

VITO - Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium.

Michelle Laeremans (M)

VITO - Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium.

Veerle J Verheyen (VJ)

VITO - Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium.

Milena Černá (M)

National Institute of Public Health, Prague, Czech Republic.

Jana Klánová (J)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Andrea Krsková (A)

National Institute of Public Health, Prague, Czech Republic.

Martin Zvonař (M)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic; Faculty of Sport Studies, Masaryk University, Kamenice 753/5, Brno, Czech Republic.

Lisbeth E Knudsen (LE)

Department of Public Health, University of Copenhagen Øster Farimagsgade 5 DK Copenhagen, Denmark.

Holger M Koch (HM)

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr University Bochum (IPA), 44789, Bochum, Germany.

Tina Kold Jensen (TK)

Faculty of Health Sciences, Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.

Loïc Rambaud (L)

Santé publique France, French Public Health Agency (SpFrance), Saint-Maurice, France.

Margaux Riou (M)

Santé publique France, French Public Health Agency (SpFrance), Saint-Maurice, France.

Nina Vogel (N)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Catherine Gabriel (C)

Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece.

Spyros Karakitsios (S)

Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece.

Nafsika Papaioannou (N)

Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece.

Denis Sarigiannis (D)

Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece; Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto - Piazza Della Vittoria 15, 27100, Pavia, Italy.

Réka Kakucs (R)

National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary.

Szilvia Középesy (S)

National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary.

Péter Rudnai (P)

National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary.

Tamás Szigeti (T)

National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary.

Fabio Barbone (F)

Department of Medicine-DAME, University of Udine, Via Colugna 50, 33100, Udine, Italy.

Valentina Rosolen (V)

Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", 34137, Trieste, Italy.

Cedric Guignard (C)

Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, 41, rue du Brill, L-4422 Belvaux, Luxembourg.

Arno C Gutleb (AC)

Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, 41, rue du Brill, L-4422 Belvaux, Luxembourg.

Amrit Kaur Sakhi (AK)

Norwegian Institute of Public Health (NIPH), Oslo, Norway.

Line Småstuen Haug (LS)

Norwegian Institute of Public Health (NIPH), Oslo, Norway.

Beata Janasik (B)

Nofer Institute of Occupational Medicine, St. Teresy 8, Lodz, Poland.

Danuta Ligocka (D)

Nofer Institute of Occupational Medicine, St. Teresy 8, Lodz, Poland.

Milada Estokova (M)

Public Health Authority of the Slovak Republic, Trnavska cesta 52, 826 45, Bratislava, Slovakia.

Lucia Fabelova (L)

Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia.

Branislav Kolena (B)

Constantine the Philosopher University in Nitra, Tr. A Hlinku 1, 94901 Nitra, Slovakia.

Lubica Palkovicova Murinova (LP)

Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia.

Ida Petrovicova (I)

Constantine the Philosopher University in Nitra, Tr. A Hlinku 1, 94901 Nitra, Slovakia.

Denisa Richterova (D)

Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia.

Milena Horvat (M)

Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia.

Darja Mazej (D)

Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia.

Janja Snoj Tratnik (JS)

Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia.

Agneta Annika Runkel (AA)

Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia.

Argelia Castaño (A)

National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain.

Marta Esteban-López (M)

National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain.

Susana Pedraza-Díaz (S)

National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain.

Agneta Åkesson (A)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Sanna Lignell (S)

Swedish Food Agency, PO Box 622, SE-751 26, Uppsala, Sweden.

Jelle Vlaanderen (J)

Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands.

Jan-Paul Zock (JP)

National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Greet Schoeters (G)

VITO - Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium.

Marike Kolossa-Gehring (M)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH